Trials / Completed
CompletedNCT06603389
The Development of Psychiatric Non-Suicidal Self-Injury Risk Assessment Scale
The Development of Psychiatric Non-Suicidal Self-Injury Risk Assessment Scale (PNSSI-RAS)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 330 (actual)
- Sponsor
- Shantou University Medical College · Academic / Other
- Sex
- All
- Age
- 12 Years – 30 Years
- Healthy volunteers
- Not accepted
Summary
Non-suicidal self-injury (NSSI) is a growing global mental health challenge, distinct from suicidal behavior, with unique risk factors and mechanisms. Existing risk assessment tools do not focus on differentiating NSSI from suicidal self-harm or comprehensively evaluate risk and protective factors specific to NSSI. There is a lack of clinically applicable, validated scales dedicated to assessing NSSI risk, particularly in psychiatric populations. The present study is made to design the Psychiatric Non-Suicidal Self-Injury Risk Assessment Scale, a 39-item scale that evaluates static/dynamic risk factors and protective factors for NSSI in psychiatric patients.
Detailed description
The initial item pool was created through literature review, semi-structured interviews, and group discussions. Two rounds of the Delphi were employed with twenty experts. We analyzed items using critical ratio, correlation coefficient, factor analysis, and Cronbach's α coefficient. Exploratory factor analysis determined item weights, while reliability analyses evaluated internal consistency, test-retest, inter-observer and split-half methods. In the validity analyses, CVI, construct validity and criterion validity were used. ROC curve established the optimal diagnostic threshold and the risk stratification was performed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Psychiatric Non-Suicidal Self-Injury Risk Assessment Scale | sacles or questionnaires |
Timeline
- Start date
- 2022-11-01
- Primary completion
- 2023-10-31
- Completion
- 2024-05-28
- First posted
- 2024-09-19
- Last updated
- 2024-09-19
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06603389. Inclusion in this directory is not an endorsement.